Sequoia Financial Advisors LLC Raises Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Sequoia Financial Advisors LLC raised its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 58.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 8,315 shares of the medical equipment provider’s stock after purchasing an additional 3,054 shares during the quarter. Sequoia Financial Advisors LLC’s holdings in Intuitive Surgical were worth $2,805,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also recently modified their holdings of the company. OFI Invest Asset Management purchased a new stake in shares of Intuitive Surgical in the third quarter worth approximately $25,000. Headinvest LLC purchased a new stake in shares of Intuitive Surgical in the third quarter worth approximately $28,000. Stone House Investment Management LLC raised its stake in shares of Intuitive Surgical by 100.0% in the third quarter. Stone House Investment Management LLC now owns 100 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 50 shares during the last quarter. Householder Group Estate & Retirement Specialist LLC purchased a new stake in shares of Intuitive Surgical in the third quarter worth approximately $30,000. Finally, Truvestments Capital LLC raised its stake in shares of Intuitive Surgical by 137.2% in the third quarter. Truvestments Capital LLC now owns 102 shares of the medical equipment provider’s stock worth $30,000 after purchasing an additional 59 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $392.26 on Friday. Intuitive Surgical, Inc. has a one year low of $254.85 and a one year high of $403.76. The business has a fifty day moving average price of $388.24 and a 200-day moving average price of $339.66. The firm has a market capitalization of $139.04 billion, a P/E ratio of 77.98, a PEG ratio of 6.03 and a beta of 1.36.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, January 23rd. The medical equipment provider reported $1.60 EPS for the quarter, topping analysts’ consensus estimates of $1.48 by $0.12. Intuitive Surgical had a return on equity of 13.11% and a net margin of 25.24%. The firm had revenue of $1.93 billion during the quarter, compared to analyst estimates of $1.89 billion. During the same period last year, the company earned $0.91 earnings per share. The business’s revenue for the quarter was up 16.6% on a year-over-year basis. Sell-side analysts expect that Intuitive Surgical, Inc. will post 4.93 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, SVP Mark Brosius sold 196 shares of the stock in a transaction on Tuesday, March 5th. The stock was sold at an average price of $400.00, for a total value of $78,400.00. Following the sale, the senior vice president now owns 1,842 shares in the company, valued at $736,800. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In related news, EVP Robert Desantis sold 20,296 shares of the stock in a transaction on Friday, March 8th. The stock was sold at an average price of $393.80, for a total value of $7,992,564.80. Following the sale, the executive vice president now owns 5,507 shares in the company, valued at $2,168,656.60. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, SVP Mark Brosius sold 196 shares of the stock in a transaction on Tuesday, March 5th. The stock was sold at an average price of $400.00, for a total value of $78,400.00. Following the completion of the sale, the senior vice president now owns 1,842 shares in the company, valued at approximately $736,800. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 248,418 shares of company stock worth $95,927,097. Corporate insiders own 0.90% of the company’s stock.

Wall Street Analysts Forecast Growth

ISRG has been the subject of several analyst reports. Stifel Nicolaus increased their price objective on Intuitive Surgical from $420.00 to $430.00 and gave the stock a “buy” rating in a research note on Monday. Truist Financial upped their target price on Intuitive Surgical from $390.00 to $435.00 and gave the company a “buy” rating in a report on Wednesday, January 24th. Royal Bank of Canada upped their target price on Intuitive Surgical from $400.00 to $432.00 and gave the company an “outperform” rating in a report on Wednesday, January 24th. Wells Fargo & Company upped their target price on Intuitive Surgical from $363.00 to $416.00 and gave the company an “overweight” rating in a report on Friday, January 19th. Finally, StockNews.com lowered Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Thursday, February 29th. Five equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus target price of $375.70.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.